c-myc Affinity Purified Antibody
Referência MBS194459-0,1mg
Tamanho : 0.1mg
Marca : MyBiosource
C-Myc (MYC) Antibody – Goat Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS194459MBS194459 is an antibody targeting MYC. Also known as c-myc Affinity Purified Antibody. Host: Goat. More details
Product Overview
Product Name
c-myc, Polyclonal Antibody
Full Product Name
c-myc Affinity Purified Antibody
Product Gene Name
anti-MYC antibody
Product Synonym Names
c-myc; c-myc
Clonality
Polyclonal
Host
Goat
Concentration
1 mg/ml (lot specific)
Specificity
c-myc [Goat polyclonal antibody to c-myc ]
Preparation and Storage
Store at 4 degree C; stable for one year
Molecular Weight
48,804 Da
Chromosome Location
Chromosome: 8; NC_000008.10 (128748315..128753680). Location: 8q24.21
OMIM
113970
Antigen
c-myc (EQKLISEEDL) coupled to KLH
Buffer
Phosphate Buffered Saline, pH 7.2.
Preservatives
0.1% sodium azide
Product Categories/Family for anti-MYC antibody
Applications Tested/Suitable for anti-MYC antibody
ELISA, Western Blot, Immunohistochemistry, Immunocytochemistry
Application Notes for anti-MYC antibody
ELISA: Coating: 2-10 ug/ml, Primary: 0.03-1 ug/ml
Western Blot: Colorimetric: 0.1-1 ug/ml, Chemiluminescent: 0.03-1 ug/ml
Immunohistochemistry/Immunocytochemistry: 0.5-5 ug/ml
Western Blot: Colorimetric: 0.1-1 ug/ml, Chemiluminescent: 0.03-1 ug/ml
Immunohistochemistry/Immunocytochemistry: 0.5-5 ug/ml
Other Notes
Small volumes of anti-MYC antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for MYC. It may not necessarily be applicable to this product.
NCBI Official Full Name
c-myc
NCBI Official Synonym Full Names
v-myc myelocytomatosis viral oncogene homolog (avian)
NCBI Official Symbol
MYC
NCBI Official Synonym Symbols
MRTL; c-Myc; bHLHe39
UniProt Protein Name
Myc proto-oncogene protein
UniProt Synonym Protein Names
Class E basic helix-loop-helix protein 39; bHLHe39; Proto-oncogene c-Myc; Transcription factor p64
Protein Family
Myc protein
UniProt Gene Name
MYC
UniProt Synonym Gene Names
BHLHE39
UniProt Entry Name
MYC_HUMAN
NCBI Protein Information
myc proto-oncogene protein; OTTHUMP00000158589; OTTHUMP00000227763; proto-oncogene c-Myc; transcription factor p64; class E basic helix-loop-helix protein 39; avian myelocytomatosis viral oncogene homolog; v-myc avian myelocytomatosis viral oncogene homolog; myc-related translation/localization regulatory factor
NCBI Summary for MYC
The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. [provided by RefSeq]
Show more UniProt Comments for MYC
Myc: a proto-oncogenic transcription factor that plays a role in cell proliferation, apoptosis and in the development of human tumors. Seems to activate the transcription of growth-related genes.
Protein type: Oncoprotein; Transcription factor; Nucleolus; DNA-binding
Chromosomal Location of Human Ortholog: 8q24.21
Cellular Component: nucleoplasm; protein complex; nucleolus; cytosol; nucleus
Molecular Function: protein dimerization activity; protein binding; DNA binding; protein complex binding; transcription factor activity; transcription factor binding
Biological Process: cellular iron ion homeostasis; oxygen transport; positive regulation of transcription, DNA-dependent; positive regulation of caspase activity; negative regulation of transcription from RNA polymerase II promoter; Wnt receptor signaling pathway through beta-catenin; chromosome organization and biogenesis; positive regulation of fibroblast proliferation; transforming growth factor beta receptor signaling pathway; positive regulation of mesenchymal cell proliferation; positive regulation of cell proliferation; response to gamma radiation; cell cycle arrest; response to drug; transcription initiation from RNA polymerase II promoter; Notch signaling pathway; regulation of telomere maintenance; transcription, DNA-dependent; MAPKKK cascade; negative regulation of cell division; negative regulation of monocyte differentiation; negative regulation of stress-activated MAPK cascade; chromatin remodeling; regulation of gene expression; ureteric bud branching; negative regulation of fibroblast proliferation; energy reserve metabolic process; positive regulation of transcription from RNA polymerase II promoter; gene expression; response to DNA damage stimulus; positive regulation of epithelial cell proliferation; negative regulation of apoptosis
Disease: Burkitt Lymphoma
Show more Protein type: Oncoprotein; Transcription factor; Nucleolus; DNA-binding
Chromosomal Location of Human Ortholog: 8q24.21
Cellular Component: nucleoplasm; protein complex; nucleolus; cytosol; nucleus
Molecular Function: protein dimerization activity; protein binding; DNA binding; protein complex binding; transcription factor activity; transcription factor binding
Biological Process: cellular iron ion homeostasis; oxygen transport; positive regulation of transcription, DNA-dependent; positive regulation of caspase activity; negative regulation of transcription from RNA polymerase II promoter; Wnt receptor signaling pathway through beta-catenin; chromosome organization and biogenesis; positive regulation of fibroblast proliferation; transforming growth factor beta receptor signaling pathway; positive regulation of mesenchymal cell proliferation; positive regulation of cell proliferation; response to gamma radiation; cell cycle arrest; response to drug; transcription initiation from RNA polymerase II promoter; Notch signaling pathway; regulation of telomere maintenance; transcription, DNA-dependent; MAPKKK cascade; negative regulation of cell division; negative regulation of monocyte differentiation; negative regulation of stress-activated MAPK cascade; chromatin remodeling; regulation of gene expression; ureteric bud branching; negative regulation of fibroblast proliferation; energy reserve metabolic process; positive regulation of transcription from RNA polymerase II promoter; gene expression; response to DNA damage stimulus; positive regulation of epithelial cell proliferation; negative regulation of apoptosis
Disease: Burkitt Lymphoma
Research Articles on MYC
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-MYC antibody
| Reference Product | PubMed Publications |
|---|---|
| MAX antibody | >892 publications with MYC and MAX |
| CDKN1A antibody | >458 publications with MYC and CDKN1A |
| CDKN2A antibody | >378 publications with MYC and CDKN2A |
| BCL2 antibody | >287 publications with MYC and BCL2 |
| SP1 antibody | >256 publications with MYC and SP1 |
| CDK4 antibody | >227 publications with MYC and CDK4 |
| E2F1 antibody | >211 publications with MYC and E2F1 |
| BRCA1 antibody | >112 publications with MYC and BRCA1 |
| MXI1 antibody | >107 publications with MYC and MXI1 |
| MAPK3 antibody | >98 publications with MYC and MAPK3 |
Pathways associated with anti-MYC antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Apoptosis Pathway antibodies | Apoptosis Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| Bladder Cancer Pathway antibodies | Bladder Cancer Pathway Diagram |
| C-MYB Transcription Factor Network Pathway antibodies | C-MYB Transcription Factor Network Pathway Diagram |
| C-MYC Pathway antibodies | C-MYC Pathway Diagram |
| CD40/CD40L Signaling Pathway antibodies | CD40/CD40L Signaling Pathway Diagram |
| Cell Cycle, Mitotic Pathway antibodies | Cell Cycle, Mitotic Pathway Diagram |
| Cell Cycle Pathway antibodies | Cell Cycle Pathway Diagram |
Diseases associated with anti-MYC antibody
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >13089 publications with MYC and Neoplasms |
| Carcinoma Antibodies | >3240 publications with MYC and Carcinoma |
| Cell Transformation, Neoplastic Antibodies | >2340 publications with MYC and Cell Transformation, Neoplastic |
| Neoplasms, Experimental Antibodies | >2016 publications with MYC and Neoplasms, Experimental |
| Neuroectodermal Tumors Antibodies | >1972 publications with MYC and Neuroectodermal Tumors |
| Neuroblastoma Antibodies | >1390 publications with MYC and Neuroblastoma |
| Adenocarcinoma Antibodies | >1373 publications with MYC and Adenocarcinoma |
| Skin Diseases Antibodies | >1285 publications with MYC and Skin Diseases |
| Disease Models, Animal Antibodies | >1235 publications with MYC and Disease Models, Animal |
| Breast Neoplasms Antibodies | >1198 publications with MYC and Breast Neoplasms |
Organs/Tissues associated with anti-MYC antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >2925 publications with MYC and Blood |
| Liver Antibodies | >1585 publications with MYC and Liver |
| Lung Antibodies | >1146 publications with MYC and Lung |
| Bone Antibodies | >1065 publications with MYC and Bone |
| Muscle Antibodies | >955 publications with MYC and Muscle |
| Brain Antibodies | >899 publications with MYC and Brain |
| Bone Marrow Antibodies | >774 publications with MYC and Bone Marrow |
| Kidney Antibodies | >719 publications with MYC and Kidney |
| Vascular Antibodies | >709 publications with MYC and Vascular |
| Embryonic Tissue Antibodies | >535 publications with MYC and Embryonic Tissue |


